Aurora Cannabis Inc. (ACB.TO)

0.6600 -0.0200 (-2.94%) As of 09:42AM EST. Market open.

Aurora Cannabis Inc.

2207 90B Street SW
Edmonton, AB T6X 1V8
Canada

https://www.auroramj.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 1,338

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Miguel Martin	CEO & Director	2.02M	N/A	1973
Mr. Glen Ibbott	Chief Financial Officer	626.43k	N/A	N/A
Mr. Alex Miller	Executive Vice President of Operations & Supply Chain	496.19k	N/A	N/A
Ms. Lori Schick	Executive Vice President of Human Resources	470.65k	N/A	N/A
Mr. Andre Jerome	Executive Vice President of Global Business Development	456.56k	N/A	N/A
Ananth Krishnan	Vice President of Capital Markets & Investor Relations	N/A	N/A	N/A
Ms. Nathalie Clark	Executive VP, General Counsel & Corporate Secretary	N/A	N/A	N/A
Michelle Lefler	Vice President of Communications & Public Relations	N/A	N/A	N/A
Dr. Jonathan Page Ph.D.	Senior Science Advisor	N/A	N/A	1969
Mr. Rick Savone	Senior Vice President of Global Government Relations	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Corporate Governance

Aurora Cannabis Inc.’s ISS Governance QualityScore as of December 1, 2023 is 7. The pillar scores are Audit: 10; Board: 5; Shareholder Rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.